Celtarys Research will attend ELRIG Drug Discovery 2021
ELRIG’s annual Drug Discovery meeting is still Europe’s largest meeting for life sciences industry professionals and will return on 19th and 20th of October 2021, to celebrate the innovation and efforts of our industry and the scientific successes that we have shared throughout the period of the pandemic.
Drug Discovery 2021 promises to be a particularly special event, providing a platform for the whole drug discovery community to meet at in-person event and Celtarys Research will be there. Don’t miss the opportunity to contact our BD to talk about our fluorescent probes and their applications in early phases of drug discovery.
- Gonzalo Pazos (BD): gonzalo.pazos@celtarys.com
Moreover, Celtarys Research has been selected from a pool of qualified candidates to represent SLAS on Innovation AveNEW at ELRIG Drug Discovery 2021.
Link of interest: ELRIG Drug Discovery 2021
Related posts
Discover Our New Fluorescent Ligands For Adrenergic Receptor
Celtarys Research, sponsor of the XIV Meeting of the Spanish Drug Discovery Network
New fluorescent tools to evaluate the therapeutic potential of phytocannabinoids
PERTE SALUD Proyecto Nº: IDI-2025-0751
Título: TERAPIAS AVANZADAS EN INMUNOONCOLOGÍA: UNA ESTRATEGIA INNOVADORA
BASADA EN LA DEGRADACIÓN DIRIGIDA DE GPCR EN EL EJE ADENOSINÉRGICOS
EIC Pathfinder; Project name: Unisens; Universal GPCR Activity Sensor for Next Generation Drug Discovery
Esta entidad fue beneficiaria de las ayudas para la ejecución de acciones de promoción exterior de las empresas gallegas. El objetivo principal de estas ayudas es incentivar la realización de acciones de promoción exterior generadoras de ventajas competitivas. El resultado que se pretende conseguir es el impulso de las pymes y sus productos y servicios, aumentando el número de empresas de base exportadora.
Celtarys Research is beneficiary of a WomenTechEU grant supporting deep-tech start-ups led by women
Principia 2021 Program
Celtarys staff has been funded by the Xunta de Galicia within the framework of the PRINCIPIA 2021 Program of the Galician Innovation Agency (GAIN)
InnovaPEME Program
Celtarys Innovation Plan has been funded by the InnovaPEME 2022 program of the Galician Innovation Agency (GAIN)
Bonos de Innovación de Celtarys Research (026)
Para promover o desenvolvemento tecnolóxico, a innovación e unha investigación de calidade. Esta operación está financiada pola Xunta de Galicia, a través de axudas concedidas pola Axencia Galega de Innovación, dentro do programa de axudas a empresa Bonos de innovación 2022.
Celtarys Research is part of the public-private consortium developing the project PREDICTEAM
New prognostic quantitative biomarker assays for predicting patient response to immune checkpoint inhibitor (ICI) treatment
NEOTEC · CDTI — Ministerio de Ciencia e Innovación
The Project ‘New chemical conjugation technology for therapeutic targets’ has been founded by CDTI under its program NEOTEC. The NEOTEC program objective is supporting the establishment and consolidation of technology-based enterprises. A technology-based company (EBT) is a company whose activity focuses on the exploitation of products or services that require the use of technologies and knowledge developed since the research activity. The EBT base their business strategy or activity in the intensive domain of scientific and technical knowledge. Budget awarded: 416.177€ | Execution dates: 1/1/2023 – 31/03/2024